Assertio Therapeutics (ASRT) - Net earnings per one share growth for the current year

Corporate emblem and logo of Assertio Holdings, Inc. (ASRT)

Assertio Holdings, Inc. (ASRT) management's pragmatic approach to M&A transactions ensures asset stability. The year-over-year percentage change in earnings per share confirms this trend, where the value of 82.10 expresses the metric level. Efficiency is increasing through billing digitalization and production outsourcing, although expansion is constrained by rising costs for patent protection and drug promotion.

ASRT assertiotx.com Earnings per share growth in current year (07/04/2022 - 06/27/2026)

Financial and market metric breakdowns for Assertio Therapeutics (ASRT)

- market capitalization indicators:
Basic company analysis:ASRT assertiotx.com
Manufactured products of Assertio Holdings

Geopolitical risks and supply chain disruptions for Assertio Holdings, Inc. (ASRT) are reflected in the year-over-year shift in earnings per share. This indicator transforms fundamental metrics into a continuous time series to determine the business phase. The calculation is based on a percentage comparison of current net earnings per share against the same period last year. This metric identifies the sustainability of the profitability trend. Ignoring credit risks during such an analysis could lead to a portfolio drawdown.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE